Envoy Medical, Inc. (ticker: COCH) is an NASDAQ-listed orthopedic, prosthetic & surgical appliances & supplies company. DredgeCap's structured extraction of COCH's SEC filings surfaces 5 active risk signals, including 3 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. COCH reported $39K in revenue and -$4.35M for the period ending 2026-03-31, with operating cash flow of -$6.06M. Cash and equivalents stood at $25.25M (up 375.4% year-over-year). Total assets of $29.82M exceed total liabilities of $19.27M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
COCH SEC Filings
Full cached SEC EDGAR filing history for COCH, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.